A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686

NCT00721812 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Bowel Diseases

Interventions

DRUG: GSK1399686

Sponsor

GlaxoSmithKline